Ranger Investment Management, L.P.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1319691
DALLAS, TX
Position in LGND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,423,519
+$27,928,700 QoQ
Shares Held
257,596
-3.9% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
5.15%
of 13F equity value
Holder Rank
#19
of 413 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ranger Investment Management, L.P. holds $99,129,559 across 2 Biotechnology names. LGND ranks #1 (82.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
257,596 | $81,423,519 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
2,115,417 | $17,706,040 |
All Filings in LGND
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,423,519 | 257,596 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $53,494,819 | 267,943 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,045,685 | 269,983 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $48,773,727 | 275,340 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $34,106,842 | 300,025 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $19,986,062 | 190,090 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,808,265 | 82,205 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,404,056 | 83,965 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $5,762,962 | 68,395 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,760,995 | 51,450 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||